Peptide occurring in Enterobacteriaceae triggers Streptococcus pneumoniae cell death by Nasher, Fauzy et al.
ORIGINAL RESEARCH
published: 10 September 2019
doi: 10.3389/fcimb.2019.00320
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 September 2019 | Volume 9 | Article 320
Edited by:
N. Luisa Hiller,
Carnegie Mellon University,
United States
Reviewed by:
Raquel Sá-Leão,
New University of Lisbon, Portugal
Jessica Kajfasz,
University of Florida, United States
Justin A. Thornton,
Mississippi State
University, United States
*Correspondence:
Lucy J. Hathaway
lucy.hathaway@ifik.unibe.ch
Specialty section:
This article was submitted to
Molecular Bacterial Pathogenesis,
a section of the journal
Frontiers in Cellular and Infection
Microbiology
Received: 28 March 2019
Accepted: 26 August 2019
Published: 10 September 2019
Citation:
Nasher F, Kwun MJ, Croucher NJ,
Heller M and Hathaway LJ (2019)
Peptide Occurring in
Enterobacteriaceae Triggers
Streptococcus pneumoniae Cell
Death.
Front. Cell. Infect. Microbiol. 9:320.
doi: 10.3389/fcimb.2019.00320
Peptide Occurring in
Enterobacteriaceae Triggers
Streptococcus pneumoniae Cell
Death
Fauzy Nasher 1,2, Min Jung Kwun 3, Nicholas J. Croucher 3, Manfred Heller 4 and
Lucy J. Hathaway 1*
1 Institute for Infectious Diseases, Faculty of Medicine, University of Bern, Bern, Switzerland, 2Graduate School for Cellular
and Biomedical Sciences, University of Bern, Bern, Switzerland, 3Department of Infectious Disease Epidemiology, MRC
Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom, 4 Proteomics and Mass
Spectrometry Core Facility, Department for BioMedical Research, University of Bern, Bern, Switzerland
Non-encapsulated Streptococcus pneumoniae often possess two genes, aliB-like ORF
1 and aliB-like ORF 2, in place of capsule genes. AliB-like ORF 1 is thought to encode
a substrate binding protein of an ABC transporter which binds peptide SETTFGRDFN,
found in 50S ribosomal subunit protein L4 of Enterobacteriaceae. Here, we investigated
the effect of binding of AliB-like ORF 1 peptide on the transcriptome and proteome
of non-encapsulated pneumococci. We found upregulation of gene expression of a
metacaspase and a gene encoding N-acetylmuramoyl-L-alanine amidase, both of which
are proposed to be involved in programmed cell death in prokaryotic cells. Proteome
profiling indicated upregulation of transcriptional regulators and downregulation of
metabolism-associated genes. Exposure to the peptide specifically triggered death in
pneumococci which express AliB-like ORF 1, with the bacteria having an apoptotic
appearance by electron microscopy. We propose that binding of the AliB-like ORF 1
peptide ligand by the pneumococcus signals a challenging environment with hostile
bacterial species leading to death of a proportion of the pneumococcal population.
Keywords: Streptococcus pneumoniae, peptide, non-encapsulated, aliB-like ORF 1, transcriptome, proteome,
cell death
INTRODUCTION
Streptococcus pneumoniae (S. pneumoniae) (pneumococcus) is a common asymptomatic colonizer
of the human nasopharynx. The human nasopharynx is an ecosystem that hosts a diverse
microbial community and we have previously proposed that pneumococcus senses bacteria in the
environment through short peptide fragments derived from these other bacterial species sharing
the same niche (Hathaway et al., 2014; Nasher et al., 2018a,b).
The multilocus sequence types (MLST) 344 and 448 consist of non-encapsulated pneumococci
and make up a phylogenetic group that clusters away from the majority of encapsulated
pneumococci (Hathaway et al., 2004; Hanage et al., 2006; Hilty et al., 2014). Non-encapsulated
pneumococci make up 10% of those isolated from the nasopharynx (Finland and Barnes, 1977;
Carvalho et al., 2003) and in a global study we found that 88% of non-encapsulated pneumococci of
the classic lineage belonged to either MLST 344 or 448 (Hilty et al., 2014). These non-encapsulated
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pneumococci have two genes in place of the capsule genes
that we named aliB-like ORF 1 and aliB-like ORF 2 due to
their 61–64.5% homology to the ATP-binding cassette (ABC)
transporter substrate binding protein gene aliB (and 62%
homology to each other) (Hathaway et al., 2004). We predicted
that aliB-like ORFs encode substrate-binding proteins due to
their homology to aliB which is found in all pneumococci
(Hathaway et al., 2004; Hilty et al., 2014).
AliB-like ORF1 binds to peptide of sequence SETTFGRDFN,
which is found in the 50S ribosomal subunit protein L4 of
Enterobacteriaceae including Klebsiella pneumoniae (Hathaway
et al., 2014) (i.e., binds to totally different peptide thanAliB whose
ligand is AIQSEKARKHN, matching 30S ribosomal protein S20)
(Nasher et al., 2018b). Secreted proteins of Escherichia coli (E.
coli) include ribosomal associated proteins of the 50S ribosomal
subunit (Nasher et al., 2018b). Incubation with E. coli reduces
the number of live pneumococci which have the AliB-like ORF
1 receptor but not those which lack the receptor (Hathaway et al.,
2014). In the presence of competence stimulating peptide (CSP),
binding of AliB-like ORF 1 to its ligand increases competence
for genetic transformation. In contrast, AliB-like ORF 2 peptide
ligand, FPPQSV, is found in proteins of Prevotella species
(Hathaway et al., 2014) and binding of AliB-like ORF 2 to its
peptide ligand leads to increased carbohydrate metabolism and
increased growth (Nasher et al., 2018a).
Here, we investigated the effect of binding of AliB-like
ORF 1 to its peptide ligand, SETTFGRDFN, on changes to
the pneumococcal transcriptome, proteome, growth, and
survival in chemically defined medium (CDM). Understanding
the interactions that occur between pneumococci and
other bacterial species in nature may indicate targets for
therapeutic interventions.
MATERIALS AND METHODS
Bacterial Strains and Culture
The Swiss non-encapsulated nasopharyngeal pneumococcal
isolate 110.58 of multilocus sequence type (MLST) ST344, and
its mutant in which aliB-like ORF1 has been inactivated (mutant
1ORF 1) have been described previously (Hathaway et al., 2004,
2014; Hilty et al., 2014). The bacteria were stored at −80◦C
using Protect bacterial preservers (Technical Service Consultants,
Heywood, UK), were grown on CSBA plates at 37◦C, 5% CO2.
5–10 colonies in 5ml brain heart infusion (BHI) broth (Becton
Dickinson and Company, le Pont de Claix, France) containing
5% fetal calf serum (FCS; Biochrom KG, Berlin, Germany) (BHI
+ FCS) were used to prepare overnight cultures.
Gene Expression Analysis by RNA-Seq and
Real-Time RT-PCR
RNA extraction was performed as described previously (Nasher
et al., 2018a), for strains 110.58 and its mutant 1ORF 1. The
bacteria were plated out on CSBA plates, incubated at 37◦C,
5% CO2 overnight, colonies picked and cultured in 5ml BHI +
FCS overnight until OD600nm = 0.4 then centrifuged at 2000 g
for 5min and the pellet washed with 5ml CDM (chemically
defined medium that contains no peptides) and centrifuged
at 200 g for 5min. The pellet was resuspended in 5ml CDM
and 500 µl of this bacterial suspension was added to 9.5ml
CDM to make a final volume of 10ml. For each strain, at
exactly OD600nm = 0.2 the culture was split into two, each tube
containing 5ml. To one tube for each strain, a final concentration
of 0.07 mg/ml of the peptide SETTFGDRFN (synthesized by
PolyPeptide Group, Strasbourg, France) was added and all tubes
incubated at 37◦C for exactly 15min. Transcription was stopped
by adding RNAprotect (Qiagen) and RNA extracted as described
previously (Nasher et al., 2018a). RNA was acquired from three
independent experiments performed on three separate days for
RNA-Seq and a further three independent experiments for real-
time RT-PCR.
For RNA-Seq, ribosomal RNA was depleted using Ribominus
(Invitrogen) and RNA purification was carried out with RNA
Clean & ConcentrationTM-5 kit (Zymo Research) following the
manufacturers’ instructions and purified RNA was eluted in 6
µl. TruSeq R© Stranded mRNA (Illumina) was used to prepare
libraries, 13 µl of Fragment, Prime, Finish Mix was added to 5 µl
of the mRNA. Fragmentation was performed for 40 s at 94◦C. An
Illumina 3000 Hi-Seq paired end sequencing platform was used
to acquire raw reads.
Analysis was carried out as follows: the reads for the forward
and reverse ends were paired and mapped on to the reference
strain, S. pneumoniae strain NT_110_58 (Accession number-
NZ_CP007593), using Bowtie2 (version 2.3.4.1) (Hathaway et al.,
2014) with the overall alignment rates above 99%. The range of
sequenced fragments was 35–151, the mean length of sequenced
fragments was 144 and the sequencing and coverage was on
2503 times the genomic size (ranging between 883 and 4,074).
Prior to the mapping step, the reads were trimmed and filtered
using Trimmomatic (version 0.36) (Bolger et al., 2014). Cuffdiff
(version 2.2.1) RNA-Seq analysis tool was used to compare
expressions levels of genes and it used 5% for false discovery rate
for the analysis as described previously (Trapnell et al., 2013).
Expression of genes of interest identified by RNA-Seq
was quantified by real-time RT-PCR as described previously
(Hathaway et al., 2007) and normalized against 16S. Primers and
probes are shown in Table 1.
Proteomic Analysis
Bacterial strain 110.58 and its mutant 1ORF 1 were plated out
on CSBA plates, incubated at 37◦C, 5% CO2 overnight, colonies
picked and cultured in 5ml BHI+ FCS overnight until OD600nm
= 0.4 then centrifuged at 2,000 g for 5min and the pellet washed
with 5ml CDM and centrifuged at 200 g for 5min. The pellet was
resuspended in 5ml CDM and 500µl of this bacterial suspension
was added to 9.5ml CDM to make a final volume of 10ml. For
each strain, at exactly OD600nm = 0.2 the culture was split into
two, each tube containing 5ml. To one tube for each strain, a
final concentration of 0.07 mg/ml of the peptide SETTFGDRFN
(synthesized by PolyPeptide Group, Strasbourg, France) was
added and all tubes incubated at 37◦C for exactly 15min. Sample
processing, LC-MS/MS and data interpretation was essentially
done as described previously (Nasher et al., 2018a). Briefly, LC-
MS/MS analysis was carried out on an Ultimate3000 nanoLC
coupled to anOrbitrap Fusion Lumos instrument (ThermoFisher
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TABLE 1 | Primers and probes used in real-time RT-PCR.
Gene Forward primer Reverse primer Probe (all with 6-FAM 5′ and MGB 3′)
16S GACGATACATAGCCGACCTGAGA GTAGGAGTCTGGGCCGTGTCT CCAGTGTGGCCGATC
lytFN1 GGACGCCAATTCCCAACCA ATGTCATGGAGGAAGAGATGGAAGAA AATGGCCTAGCATTTTC
(SpnNT_01010)
lytFN2 CAACGCTTCCAACTGTAACATCAG GCCGAACAATTCTTCCTGGTTTAAT CTTCACGCCAAGCAAC
(SpnNT_01011)
pnuC CGACAAACTCCTGCTTTTCCTTCT TGCAGCCAATTGGACTTCTAGTT CTGTGCCTGATAAATC
mtrR GGCCAATTGAATTACTCTAGCTTCCT CAGACCTTTATTTGGTTTGGGTTCAC CTGGCCTCCCGGAAAA
clpC_1 ATCCTGTAACAGATGTGCATGCT CTCAACAGCTTTTTCTTGCTTGTCT TTTCTGCCTCAATTTC
ccpA TGTAGATAAGCCATAAATGACTTTT- TGGTTGCTTATGGGAGGAGAATC ACGCACACCTCTTTCA
AAATCCATAAAGTAAT
Scientific). Full MS scans in the range of 400–1,400 m/z were
acquired in the orbitrap at 120,000 resolution with AGC set to
4e5 and maximal ion injection time of 50ms. Peptide precursors
with charge 2–8 were fragmented once in the ion trap then
excluded for 30 s. The ion trap setting were data-dependent MS2
cycle time of 3 s, isolation width of 1.6 m/z, fragmentation HCD
mode with 30% normalized collision energy, AGC of 1e4 with
maximal ion injection time of 35ms. The LC-MS/MS data was
processed with MaxQuant (version 1.5.4.1) using default settings
for peak detection, strict trypsin cleavage rule was used and
up to three missed cleavages were allowed, variable oxidation
on methionine and acetylation of protein N-termini with strict
carbamidomethylation of cysteines. A retention time window
of 0.7min was activated between runs. The fragment spectra
were interpreted with the S. pneumoniae ensemble database
(version gca_000817005_ASM81700v1). The normalized label-
free protein intensities (LFQ) as calculated by the MaxQuant
software were submitted for a differential protein expression
analysis. For this, missing LFQ values were imputed from the
low end of the LOG2 transformed intensity distribution of each
LC-MS/MS run, when there was at least one valid LFQ value
within the six replicates of each sample. Otherwise, missing
values were replaced by zero as suggested by Lazar et al. (2016).
Differential protein expression analysis was performed with t-
tests within Perseus (version 1.5.5.3), including a permutation-
based false discovery rate estimation to correct for multiple
testing. Differential expression was accepted with a 5% false
discovery rate and a minimal LOG2-fold-change of two by
applying the S0 function (set at 0.5).
Growth Measurement
Following overnight growth on CSBA plates at 37◦C, 5%CO2, the
bacteria were sub-cultured in BHI+ FCS and grown to OD600nm
0.5 and then centrifuged at 3,000 g for 5min. The bacteria
were resuspended in CDM containing 5.5mM glucose (Schaffner
et al., 2014) to give a starting OD450nm of 0.01. The growth was
monitored as described previously (Hathaway et al., 2012) in
sterile flat-bottomed 96-well microtitre plates (Nunclon Surface,
Nunc, Denmark) based on the method of Brewster (Brewster,
2003); 200 µl bacteria culture was incubated per well at 37◦C and
OD450nm wasmeasured every 30min by a VERSAmaxmicroplate
reader (Molecular Devices) for 22 h with 5 s of automatic shaking
preceding each reading. Condensation was prevented by pre-
treating the plate lids with 3ml 0.05% Triton X-100 in 20%
ethanol (Hathaway et al., 2012).
Growth Competition Assay
Wild type strain 110.58 and mutant 1ORF 1 were streaked
onto CSBA plates and incubated at 37◦C in a 5% CO2-enriched
atmosphere overnight then sub-cultured in 5ml BHI + FCS
medium to OD600nm 0.5, centrifuged at 3000 g for 5min and
resuspended in 5ml CDM. Two hundred fifty microliter of each
bacterial culture was transferred to 4.5ml CDM, pre-warmed to
37◦C, with and without AliB-like ORF 1 ligand SETTFGRDFN
at a final concentration of 0.07 mg/ml and the culture incubated
to OD600nm 0.3. Serial dilutions in PBS were plated onto CSBA
plates with and without 3µg/ml chloramphenicol to select
between the wild type (chloramphenicol susceptible) strain and
the 1ORF 1 mutant (resistant). After overnight incubation,
the number of colonies was counted and the colony forming
units (CFU) for each strain calculated. For the wildtype, CFU
was calculated by subtracting the number of colonies on the
chloramphenicol plates from the number of colonies on CSBA.
Enumeration of Live/Dead Cells by
Microscopy
The effect of theORF 1 peptide was also observedmicroscopically
using LIVE/DEADTM BacLightTM assay kit (Thermo Fisher
Scientific). Streptococcus pneumoniae strains 110.58 and mutant
1ORF 1 were cultured in 5ml CDM until exponential growth
phase, ORF 1 peptide was added to a final concentration
of 0.07 mg/ml and incubated at 37◦C for 30min. The cells
were centrifuged at 3,000x g for 10min, resuspended in
sterile phosphate-buffered saline (PBS) and stained with
LIVE/DEADTM BacLightTM bacterial viability kit as per
manufacturer’s instructions. The bacteria suspension was
pipetted onto a microscope slide and a coverslip applied
firmly. The slides were viewed using a Zeiss Axio Imager M1
fluorescence microscope with a 20 X objective and photographed
by a Zeiss AxioCam HRc camera.
For quantification of green (live) and red (dead) cells, the
images were analyzed with ImageJ software (Rueden et al.,
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2017). Each image contained between 96 and 620 bacteria, five
images were counted per group in each of three independent
experiments making a total of 15 images per group. Each data
point in Figure 3B represents one image.
Electron Microscopy
Streptococcus pneumoniae strains 110.58 and mutant 1ORF 1
were cultured in 5ml CDM until exponential growth phase, ORF
1 peptide was added to a final concentration of 0.07 mg/ml and
incubated at 37◦C for 30min. The bacteria were pelleted by
centrifugation (5,000 rpm for 5min) and the supernatant was
discarded. Bacteria were then cryopreserved by high-pressure
freezing (HPF) as described in Studer et al. (2001) using 1.4
x 0.1mm membrane carriers (Leica Microsystems, Vienna)
coated with L-α-phosphatidylcholine (Fluka, Buchs, Switzerland)
(Studer et al., 2001). Acetone containing 2 % osmium tetroxide,
0.1% uranyl acetate, 0.2% ruthenium hexamine trichloride
(RHT) and a total of 4% H2O served as medium for freeze
substitution (FS). After substitution bacteria were washed in
acetone (Merck, Darmstadt, Germany) for four times 30min,
they stayed then for 2 h 30min in acetone-Epon (2:1) and 4 h
in acetone -Epon 1:1 followed by an overnight incubation with
acetone -Epon 1:2 at room temperature. The next day, samples
were embedded in Epon (Sigma-Aldrich, Buchs, Switzerland)
and left to harden at 60◦C for 5 days. Sections were produced with
an ultramicrotome UC6 (Leica Microsystems, Vienna, Austria),
first semithin sections (1µm) for light microscopy which were
stained with a solution of 0.5% toluidine blue O (Merck,
Darmstadt, Germany) and then ultrathin sections (75 nm) for
electron microscopy. The sections, mounted on Formvar R© (Ted
Pella Inc. USA) coated single slot copper grids, were stained
with Uranyless (Electron Microscopy Sciences, Hatfield, USA)
and lead citrate (Leica Microsystems, Vienna, Austria) with an
ultrostainer (LeicaMicrosystems, Vienna, Austria). Sections were
then examined with a transmission electron microscope (CM12,
Philips, Eindhoven) equipped with a digital camera (Morada,
Soft Imaging System, Münster, Germany) and image analysis
software (iTEM).
Statistical Analysis
Unless otherwise stated, student t-tests were performed to
obtain p-values using the software GraphPad Prism (Version 7,
GraphPad Software, Inc.).
RESULTS
AliB-Like ORF1 Peptide Affects Expression
of Genes Involved in Cell Death and
Metabolism
To identify the key regulatory changes triggered by the signaling
through ORF1 in response to its ligand, RNA-Seq was used
to identify differentially expressed genes in strain 110.58 and
its 1ORF 1 mutant in the presence and absence of peptide
SETTFGRDFN. The inherent difference in gene expression
between the 110.58 and its 1ORF 1 mutant in the absence of
the peptide is shown in Table S1. Exposure to the ORF 1 ligand,
SETTFGRDFN, for 15min caused changes in gene expression
in both the 110.58 and in the 1ORF 1 mutant. In the mutant,
7 genes were significantly upregulated at least 2-fold in the
presence of the peptide: metF, metE, pyrP, nanB carA, patB_2,
and paaI with roles in carbon, pyrimidine, amino acid and
fatty acid metabolism. Twenty one genes were downregulated at
least 2-fold in the mutant plus peptide including those involved
in purine biosynthesis (purC, purL, purM). Twenty six genes
were significantly upregulated and 50 downregulated in total,
see Table S2 for expression of all genes. However, a different
pattern of expression was seen in the wild type strain: Genes that
were significantly upregulated or downregulated in the wild type
following exposure to the ORF 1 peptide ligand are shown in
Table 2. Tables with all the genes affected by the peptide in the
wild type strain are shown in Table S3.
SETTFGRDFN peptide caused significant upregulation of 5
genes in the wild type strain but not the mutant; the two
most upregulated genes, which we have named lytFN1 and
lytFN2, encode a caspase superfamily domain protein peptidase
C14 and an N-acetylmuramoyl-L-alanine amidase family protein
respectively, and are expected to degrade cell wall peptidoglycan
and play a role during cell death. However, it must be noted
that expression of lytFN1 and lytFN2 also differed between
the wildtype and its mutant in the absence of peptide, for
as yet unknown reasons. Other upregulated genes included
dpnM, which encodes DNA modification methylase and ccpA, a
catabolite control protein.
Four genes were significantly downregulated in the wild type
strain 110.58, but not the mutant, in the presence of the peptide:
pnuC, encoding a transporter involved in nicotinamide adenine
dinucleotide biosynthesis, pacS encoding a metal ion transporter
component, catE encoding a catechol-2,3-dioxygenase, and clpC
encoding an ATP-dependent protease subunit. These were all the
significant changes in the wild type induced when the peptide was
added. The genes highlighted in bold in Table 2 were chosen for
RT-PCR and confirmed the RNA-Seq findings (Figure S1).
The Proteomic Profile Indicates Peptide
Induces Transcriptional Regulators and
Downregulates Metabolism
To determine whether changes seen in gene transcription are
translated into changes at the protein level, proteomic analysis
was performed by LC-MS/MS on wild type strain 110.58 and
mutant 1ORF 1 with and without exposure to AliB-like ORF
1 peptide ligand SETTFGRDFN. Table 3 shows all proteins for
which expression was significantly upregulated or downregulated
in 110.58 following exposure to ORF 1 peptide for 15min. (All
the proteins affected by the peptide in the wild type strain and
its 1ORF 1 mutant are shown in Table S4. Table S5 shows the
proteomic profile of the wild type and mutant in the absence of
peptide; Table S6 the mutant with and without the peptide and
Table S7 the wild type with and without the peptide). LytFN1
and LytFN2 did not appear in the significantly upregulated
proteins which we speculate is because the timepoint is too
early for their transcripts to have been translated into protein.
The protein PadR family transcriptional regulator, associated
with stress response in S. pneumoniae (Liu et al., 2017), was
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TABLE 2 | Significantly upregulated and downregulated genes in the wild type pneumococcal strain 110.58 following exposure to 0.07 mg/ml of ORF 1 peptide ligand
SETTFGRDFN.
Gene number Gene name Description of product Ratioa
UPREGULATED
SpnNT_01010 lytFN1 Caspase superfamily domain protein, peptidase C14 5.4
SpnNT_01011 lytFN2 N-acetylmuramoyl-L-alanine amidase family protein 3.8
SpnNT_02122 hypothetical protein 2.7
SpnNT_01883 dpnM Modification methylase DpnIIA 2.6
SpnNT_01860 ccpA_1 Catabolite control protein A 2.4
DOWNREGULATED
SpnNT_01892 pnuC Nicotinamide riboside transporter 3.1
SpnNT_00711 pacS Cation-transporting ATPase 3.0
SpnNT_00097 catE Catechol-2,3-dioxygenase 2.9
SpnNT_00332 clpC_1 putative ATP-dependent protease subunit 2.8
aRatio is the fold difference of the gene in the presence of peptide SETTFGRDFN compared to in its absence. Genes hightlighted in bold were chosen for RT-PCR which confirmed the
RNA-Seq findings.
significantly upregulated. Furthermore, amino acid synthesis
associated repressor protein GlnR and a putative eﬄux pump
repressor MtrR were also upregulated. Proteins involved in
sugar uptake and carbohydrate metabolism were downregulated,
such as GmuD_1, a methyl beta-D-glucoside-6-phosphate
glucohydrolase, LicC_2, a phosphotransferase system (PTS)
lichenan-specific EIIC component. Transcriptional regulators
and metabolism associated proteins are highlighted in bold
in Table 3.
ORF 1 Peptide Ligand Causes Cell Death in
the Wild Type Strain 110.58
Growth in CDM was determined by measuring optical density
(OD) over time for wild type strain 110.58 in the absence
(control) and presence of AliB-like ORF 1 peptide ligand
SETTFGRDFN. In the absence of the peptide, wild type strain
110.58 had a growth advantage over its mutant 1ORF 1
(Figure 1). The peptide boosted growth of the 1ORF 1 mutant
but not the wild type strain. Growth curves were performed
with 4 different doses of ORF 1 peptide ligand in each of three
independent experiments on three different days. The mean
values for all doses, with error bars showing standard error, are
shown in Figure S2.
We also tested the effect of the ORF 1 peptide on the number
of live bacteria by plating out and counting CFU at different time
points during exponential growth (Figure S3). This indicated a
slight (non-significant) reduction in live bacteria for the wild type
110.58, but a significant increase in number of live bacteria for the
1ORF 1mutant, in line with the growth curve results in Figure 1.
Given the findings on growth, next we compared 110.58 and
1ORF 1mutant in competition assay in the presence and absence
of ORF 1 peptide. Figure 2A shows that 110.58 is outcompeted
by the mutant lacking AliB-like ORF 1 (1ORF 1) when the ORF
1 peptide is present. The wild type strain 110.58 outcompetes its
1ORF 1 mutant when the ORF 1 peptide is absent (Figure 2B),
in agreement with the growth curve results of Figure 1.
Given the outcome of the growth and competition assays
and the finding that a caspase family gene is upregulated by
the ORF 1 peptide (although we have not investigated the role
further by making a knockout), we investigated the effect of ORF
1 peptide on cell death. Strain 110.58 wildtype and its mutant
were incubated with the ORF 1 ligand for 30min in the presence
of fluorescent dyes STYO 9 and propidium iodide. Bacteria
cells were visualized using fluorescent microscopy. Streptococcus
pneumoniae cells with damaged membrane appear red and are
considered dead, whereas cells with an intact membrane appear
green. Figure 3A shows that ORF 1 peptide increased the number
of dead (red) bacteria for the wild type strain 110.58 but not
the 1ORF 1 mutant. There were more live (green) bacteria in
the 1ORF 1 mutant treated with ORF 1 peptide than any of
the other groups as expected since the ORF 1 peptide increases
growth of the 1ORF 1 mutant. The percentage of dead cells
was quantified (Figure 3B). This confirmed that ORF 1 peptide
caused a significant increase in the percentage of dead cells only
for the wild type 110.58 strain. The effect was specific to the
ORF 1 peptide SETTFGRDFN as the effect was not seen when
peptide with a single amino acid substitution (SETTFGREFN)
was used instead. The increase in number of live wild type
bacteria stimulated by the ORF 1 peptide approximately equals
the amount of cell death that the peptide causes. The consequence
of this is that the number of live bacteria remains constant, in
agreement with the data enumerating live CFU at exponential
growth phase in Figure S3.
To assess further the effect of the ORF 1 peptide on
pneumococcal cell death, strain 110.58 and its mutant were
incubated with the ORF 1 ligand for 30min, harvested and
examined by TEM. In the absence of the ORF 1 peptide,
S. pneumoniae strain 110.58 cells had a normal diplococcal
appearance (Figure 4a). In the presence of the ORF 1
peptide, some cells appeared to have apoptosis-like morphology:
disrupted structures and shrinkage with loss of coccal shape
(Figure 4b). Additional micrographs are shown in Figure S4
where “ghost cells” with cleared cytoplasm can be seen. The
1ORF 1 mutant cells in the presence and absence of the ORF
1 peptide appeared to have a typical pneumococcal appearance
(Figures 4c,d).
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TABLE 3 | Upregulated and downregulated proteins in the wildtype strain 110.58 in the presence of 0.07 mg/ml of ORF 1 peptide ligand SETTFGRDFN.
Protein number Protein name Function Ratioa q
UPREGULATED
AJD71059 PadR family
transcriptional
regulator
Lineage-specific thermal regulator protein Infiniteb 0
AJD72039 XseB Exodeoxyribonuclease VII activity 11.1 0
AJD71512 VanYB Serine-type D-Ala-D-Ala carboxypeptidase activity 4.6 0
AJD71029 SorB_1 Sorbose-specific phosphotransferase enzyme 4.6 0.007
AJD71397 GlnR Glutamine/glutamate synthetase repressor 1.7 0.008
AJD71668 MtrR Transcriptional regulator 1.8 0.008
AJD73064 RlmA 23S rRNA (guanine(748)-N(1))-methyltransferase activity 1.5 0.009
DOWNREGULATED
AJD71629 PyrF_1 Catalyzes the decarboxylation of orotidine 5’-monophosphate (OMP) to
uridine 5’-monophosphate (UMP). (de novo Pyrimidine biosynthesis)
Infiniteb 0
AJD71208 GmuD_1 Methyl beta-D-glucoside-6-phosphate glucohydrolase activity
(carbohydrate metabolic process)
Infiniteb 0
AJD71067 SdhA Iron-binding, L-serine ammonia-lyase activity 11.3 0
AJD71445 HHE Hemerythrin cation binding domain protein 5.8 0.001
AJD72972 LicC_2 Phosphotransferase system (PTS) lichenan-specific EIIC
component
3.4 0.002
AJD72365 IscS_2 Cysteine desulfurase activity 3.4 0.003
AJD71048 SaeS Histidine kinase phosphorelay sensor kinase activity 3.3 0.005
AJD72932 RmuC Recombinase 3.2 0.006
AJD71129 CorA metal ion transmembrane transporter activity 2.8 0.006
AJD72642 macB_1 Putative ABC transporter ATP-binding protein; part of the ABC
transporter complex macAB involved in macrolide export.
2.7 0.006
AJD71758 YbiV Sugar phosphatase 2.3 0.008
aRatio is the fold difference of the protein in the presence of ORF 1 peptide compared to in its absence.
bThe value in the absence of peptide was 0 so fold change in the presence of peptide could not be calculated.
Transcriptional regulators and metabolism associated proteins are highlighted in bold.
FIGURE 1 | Growth analysis of pneumococcal strain 110.58 and its mutant 1 ORF 1 in the presence and absence of 0.062 mg/ml of ORF 1 peptide. Curves show
the mean optical density values over time of three independent experiments performed on different days.
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FIGURE 2 | Competition assay between strain 110.58 and its mutant 1ORF 1
when cultured together in CDM. Strain 110.58 was cultured together with its
mutant 1ORF 1 (A) in the presence (0.07 mg/ml) or (B) absence of ORF 1
peptide. When OD600nm reached 0.1, 0.2 and 0.3, the bacteria were plated
onto CSBA with and without 3µg/ml of chloramphenicol to differentiate
between the wild type and the mutant and cfu counted. Results are presented
as mean values ± s.d. of three independent experiments. *p = 0.0032; **p =
0.0021; ****p < 0.0001; ns, not significant.
DISCUSSION
Non-encapsulated pneumococci are considered to be less
virulent than encapsulated strains but are sometimes isolated
from sterile sites and make up more than 10% of nasopharyngeal
isolates (Finland and Barnes, 1977; Carvalho et al., 2003).
Current vaccines offer no protection against non-encapsulated
strains and this may be selecting for their increased prevalence
(Sá-Leão et al., 2009).
Non-encapsulated S. pneumoniae of multilocus sequence
type 344, such as Swiss strain 110.58, have interesting features
including increased colonization ability and transformation
rate compared to encapsulated strains (Hathaway et al., 2004;
Hanage et al., 2006; Hilty et al., 2014). They have two
genes, aliB-like ORF 1 and aliB-like ORF 2, in place of the
capsule genes, that are homologs of the gene encoding AliB
substrate binding protein, found in all pneumococci (Hathaway
et al., 2004). Previously, we have proposed a mechanism of
interspecies communication consisting of specific binding of
peptides derived from other bacterial species found in the
nasopharyngeal microbiota via such substrate binding proteins,
triggering changes in pneumococcal phenotype (Hathaway et al.,
2014; Nasher et al., 2018a,b,c). AliB-like ORF 1 binds specifically
to peptide SETTFGRDFN, matching 50S ribosomal subunit
protein L4 of Enterobacteriaceae, promoting competence for
genetic transformation in the presence of CSP (Hathaway et al.,
2014). Exposure to E. coli, not a usual nasopharyngeal resident,
which possesses the peptide, specifically reduced the number of
live AliB-like ORF 1-expressing pneumococci. Here, the aim was
to investigate how binding of AliB-like ORF 1 peptide affects
pneumococcal phenotype. Our main conclusion is that specific
binding of ORF 1 peptide to its receptor, as would occur in
a stressful environment, causes S. pneumoniae to respond by
undergoing apoptosis in a proportion of the population. We
speculate that this is a mechanism to promote transmission of
the remaining living pneumococci.
We were led to this conclusion by the following: The
transcriptome profile of the wild type strain obtained by RNA
sequencing showed upregulation of lytFN1, a gene encoding a
caspase superfamily domain protein; peptidase C14 following
exposure to the peptide. This was confirmed by real-time RT-
PCR. In prokaryotes, caspase homologs are dubbed metacaspases
(Asplund-Samuelsson et al., 2012), and have been reported
to play a role in programmed cell death (PCD) in some
bacteria including Xanthomonas campestris and Trichodesmium
erythraeum (Berman-Frank et al., 2004; Wadhawan et al.,
2010). Metacaspases may be cotranscribed with genes involved
in hydrolysis, carbon metabolism and signaling processes
(Asplund-Samuelsson et al., 2012). This is interesting because
the adjacent gene, lytFN2, encoding an N-acetylmuramoyl-L-
alanine amidase family protein was also upregulated in our
RNA-Seq and real-time RT-PCR data following exposure to
the peptide in the wild type. The product of this gene is
a peptidoglycan hydrolase (Vollmer et al., 2008): a group of
proteins associated with fratricide and the development of
autolysis. Peptidoglycan hydrolases cleave elements of bacterial
cell wall and Staphylococcus aureus amidases have been shown
to have a role in PCD (Rice and Bayles, 2003). PCD has been
reported to occur as a consequence of stress in Xanthomonas
species (Chaloupka and Vinter, 1996; Berman-Frank et al., 2004;
Wadhawan et al., 2010), as a defense mechanism during phage
infections (Hazan et al., 2004) and during antibiotic treatment in
E. coli (Chaloupka and Vinter, 1996). The role of peptidoglycan
hydrolases in autolysis and fratricide supports our hypothesis
that lytFN1 and lytFN2 may play a combined role in PCD in
response to the AliB-like ORF 1 peptide ligand. LytFN1 and
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FIGURE 3 | Results of LIVE/DEADTM BacLightTM bacterial viability visualized by fluorescence microscopy. (A) Streptococcus pneumoniae strain 110.58 and 1ORF 1
mutant in the presence (0.07 mg/ml) or absence of the ORF 1 peptide. Damaged membrane causes dead bacteria to appear red whereas live cells with an intact
membrane appear green. All panels are at the same magnification. (B) Quantification of the red cells presented as percentages. “Changed amino acid” refers to use of
a peptide with a single amino acid substitution (SETTFGREFN) instead of ORF 1 peptide (SETTFGRDFN). Results are shown as the mean ± s.d. of three independent
experiments ****p < 0.0001; ns, not significant.
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FIGURE 4 | Transmission electron micrographs showing the morphological appearance of S. pneumoniae strain 110.58 and its 1ORF 1 mutant in the presence (0.07
mg/ml) and absence of ORF 1 peptide (magnification, ×53,000). (a) 110.58 control, (b) 110.58 + ORF 1 peptide, (c) 1ORF1 mutant control, and (d) 1ORF1 mutant
+ ORF 1 peptide (Background staining is artifactual).
LytFN2 did not appear in the significantly upregulated proteins
which we speculate is due to the timepoint being too early for
their transcripts to be translated into protein.
Although we have not shown directly that LytFN1 and LytFN2
cause pneumococcal death in response to ORF 1 peptide, their
predicted functions led us to our principal finding that ORF 1
peptide increases cell death specifically when bound by AliB-
like ORF 1. When taken up by another route, as in the 1ORF
1 mutant, cell death is not observed but rather the bacteria use
the peptide to boost growth. LytFN1 and lytFN2 are present
at about 7% frequency in the pneumococcal population in
both encapsulated and nonencapsulated pneumococci (Croucher
et al., 2015). However, the link between PCD and ORF 1 peptide
would only be seen in pneumococci which possess AliB-like
ORF 1 and we do not exclude that these genes could also be
involved in fratricide since they share homology with other cell
wall hydrolases.
Binding of ORF 1 peptide to its receptor has been proposed
to trigger a stress response in the pneumococcus (Hathaway
et al., 2014) and we did find upregulation of the stress-related
protein PadR-like family transcription regulator protein and
transcription of dpnM associated with competence for genetic
transformation (Johnston et al., 2013). The pneumococcus has
been reported to undergo competence for genetic transformation
during stressful conditions (Engelmoer and Rozen, 2011),
although we did not see upregulation of other competence genes.
In our previous study (Hathaway et al., 2014) we reported
an increase in competence for genetic transformation in the
presence of the ORF 1 peptide ligand together with CSP.
The regulatory link between metabolism and PCD has
been reported to be widespread in nature (van den Esker
et al., 2017). ccpA gene, encoding catabolite control protein
A, was upregulated in response to ORF 1 peptide. CcpA is
a transcriptional regulator that affects the expression of over
15% of the pneumococcal genome, including genes involved
in virulence, regulation and central metabolism (Görke and
Stülke, 2011). Regulating genes that are used to catabolize a
specific carbon source until the cell has exhausted the favored
source is a strategy that allows for maximum fitness, and is
usually achieved by regulation of genes through global regulators
(Carvalho et al., 2011; Görke and Stülke, 2011). We also noticed
changes in expression of other metabolism-associated proteins
in response to the ORF 1 peptide. Although the association
between ccpA and the metabolism-associated genes shown here
to be affected by the ORF 1 peptide has not been reported,
it is plausible that this transcriptional regulator might have
an indirect effect on their regulation. It is worth noting that
in the experiments performed here in vitro we used CDM
supplemented with glucose and studied planktonic growth. In
vivo during nasopharyngeal colonization the pneumococci would
be expected to form biofilm and to use galactose as their principal
carbon source (Blanchette et al., 2016). Therefore, we cannot rule
out that the effect of ORF 1 peptide on pneumococci in their
natural environment would differ from that reported here.
ORF 1 peptide caused death of a proportion of the
pneumococcal population but only when bound by the AliB-
like ORF 1 receptor. The number of dead cells was equivalent
to the number of additional live bacteria produced in response
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to the peptide meaning that the population of live bacteria
remained stable. In order to study the cell death further we
looked at the phenotype of the bacteria, following exposure to
the peptide, by electron microscopy. Death of pneumococci by
autolysis during stationary phase has been described to be due
to the production of hydrogen peroxide by SpxB resulting in
a death process exhibiting features of apoptosis (Regev-Yochay
et al., 2007). These features were increased annexin V staining,
decreased DNA content and apoptotic appearance by electron
microscopy. Here, following exposure of wild type cells to ORF 1
peptide, we also saw features of apoptosis by electron microscopy
despite the fact that our bacteria were in exponential phase
rather that stationary phase. We observed shrinkage with loss of
coccal shape and disruption of internal structures after 30min
of incubation of wild type pneumococci with peptide similar to
the phenotype that Regev-Yochay et al. (2007) saw six hours into
stationary phase. After only 30min of exposure to peptide some
pneumococci already had the phenotype of “ghost cells”. Ghost
cells were described by Regev-Yochay et al. (2007) at twelve hours
of stationary phase as having clearly disrupted structures, loss of
coccal shape and clearing of the cytoplasm. In our experiments
the appearance of the bacteria by electron microscopy and the
activation of the caspase and amidase genes lead us to speculate
that the cells are undergoing PCD.
We predict that pneumococci undergoing PCD would release
pneumolysin, thereby increasing transmission of the remaining
live population to a new host and thus escaping from the
hostile environment. The mechanism of pneumolysin-mediated
transmission has been reported in an in vivomouse model (Zafar
et al., 2017). Although AliB-like ORF 1 may bind other peptides
from the environment and the effect could be different from that
reported here, it would be interesting to determine the effect
of its peptide ligand on transmission in vivo. The relevance of
this phenotype is linked to the universal prevalence of AliB-like
ORF 1 in the classic lineage of non-encapsulated pneumococci,
a population with high non-susceptibility rates to β-lactams
and other antimicrobials (Hilty et al., 2014). AliB-like ORF 1
ligand is found in the 50S ribosomal subunit protein L4 of many
Enterobacteriaceae species including Klebsiella pneumoniae, a
respiratory pathogen which may occupy the same niche as S.
pneumoniae, and E. coli (Hathaway et al., 2014). Proteobacteria
have been found to increase in the respiratory tract during
dysbiosis, for example during asthma (Hilty et al., 2010).
In summary, we did see a link between the pneumococcal
transcriptome, proteome, and phenotype in response to the ORF
1 peptide. We propose that uptake of ORF 1 peptide by a route
other than by the specific AliB-like ORF 1 receptor stimulates
metabolism and growth, as seen in the1ORF 1mutant. However,
uptake via the AliB-like ORF 1 receptor in the 110.58 wild
type strain leads to expression of genes linked to autolysis,
proteins associated with a stress response and ultimately
cell death.
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